Ulipristal acetate

Jan 11, 2019

Information Update - Health Canada safety review finds possible link between Fibristal and risk of liver injury

Aug 21, 2018

Allergan Receives Complete Response Letter from the U.S. Food and Drug Administration for Ulipristal Acetate New Drug Application

Mar 15, 2018

Information Update - Health Canada to conduct review of a new potential safety risk of Fibristal (ulipristal acetate), a medication used to treat fibroids

Feb 28, 2018

Allergan Announces FDA Has Extended The Ulipristal Acetate NDA Review Period To August 2018

Oct 31, 2017

Allergan Presented New Phase 3 Data of Ulipristal Acetate in Women with Uterine Fibroids at the American Society for Reproductive Medicine Annual Congress

Oct 23, 2017

Allergan to Present Latest Studies of Ulipristal Acetate for Uterine Fibroids at the American Society for Reproductive Medicine 73rd Annual Congress

Oct 10, 2017

Allergan Announces that the FDA Accepts New Drug Application for Ulipristal Acetate for Uterine Fibroids

Sep 15, 2017

First-ever Uterine Fibroid Patient Registry Aims to Shed Light on Burden for Thousands of Canadian Women

Aug 29, 2017

Bayer announces enrollment of first U.S. patient in Phase III trials of vilaprisan in uterine fibroids